Regulatory News
Wednesday, June 1, 2016
BRIEF-Allergan receives FDA approval to market Juvéderm Volbella XC
* Received approval from U.S. Food And Drug Administration
(FDA) to market Juvéderm Volbella XC
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment